Wyoming API maker Cody Labs nabs $11M loan from state to expand operations


Cody Labs, a subsidiary of Lannett Company of Philadelphia, roped in an $11 million loan from the state of Wyoming that will be used to expand the API maker’s operations.

Cody Labs, which is based in Cody, WY, manufacturers APIs and finished dosage forms of pain relief medication. The company, which employs more than 100 people, was granted an import license in 2008 to import raw opiate material to produce painkillers.

Approval of the loan, which was part of a $41 million package approved by the State Loan and Investment Board that included two other companies, must still pass a legal and technical review before it is dispensed.


Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This on-demand webinar discusses the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

Bernhard Opitz, an officer with Cody Labs, told the board about 5 tons of pharmaceutical products are manufactured at the facility each year and the company plans to add 11 tons annually through its planned expansion, The Associated Press reported. The company expects to hire more workers with the expansion.

“We very much appreciate the statement of trust and support in our project,” Opitz said of the board’s approval of the loan.

- check out the AP story 

Related Article:
AMRI, Saneca Pharma team to produce a range of opium-based APIs


Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.